Anti-Inflammation and Anti-Oxidation: The Key to Unlocking the Cardiovascular Potential of SGLT2 Inhibitors and GLP1 Receptor Agonists

• Main Authors: Veronika A. Myasoedova (Author), Michele Bozzi (Author), Vincenza Valerio (Author), Donato Moschetta (Author), Ilaria Massaiu (Author), Valentina Rusconi (Author), Daniele Di Napoli (Author), Michele Ciccarelli (Author), Valentina Parisi (Author), Piergiuseppe Agostoni (Author), Stefano Genovese (Author), Paolo Poggio (Author)
• Format: Book
• Published: MDPI AG, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Type 2 diabetes mellitus (T2DM) is a prevalent and complex metabolic disorder associated with various complications, including cardiovascular diseases. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) have emerged as novel therapeutic agents...